Literature DB >> 20057161

Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.

Guodong Kang1, Lu Guo, Zhirong Guo, Xiaoshu Hu, Ming Wu, Zhengyuan Zhou, Hui Zhou, Shijun Liu, Fengmei Chen.   

Abstract

BACKGROUND: Few prospective studies have explored blood pressure (BP) and other components of the metabolic syndrome (MetS) and their interaction in the development of cardiovascular diseases (CVD) in China. METHODS AND
RESULTS: A prospective study of the prevention of multiple metabolic disorders and MetS in Jiangsu province, China: 3,598 subjects were followed for a median of 6.3 years. The Asian criterion of the National Cholesterol Education Program Adult Treatment Panel III was used to define the MetS. Independent risk of the MetS and its components on developing CVD was analyzed, but only BP was associated with CVD. Incidence and risk of CVD increased with the number of MetS components. A linear association was found between the risk of CVD, BP and the number of other components (trend, P<0.01). The adjusted relative risk of developing CVD was increased when BP and other components coexisted. However, the interaction of BP and other components of MetS was not significant (P>0.05).
CONCLUSIONS: In Chinese, among the components of MetS BP was an independent risk factor for CVD. No significant interaction was found between BP and the other MetS components.

Entities:  

Mesh:

Year:  2010        PMID: 20057161     DOI: 10.1253/circj.cj-09-0422

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.

Authors:  Nima Motamed; Hossein Ajdarkosh; Mohammad Hadi Karbalaie Niya; Mahshid Panahi; Behzad Farahani; Nader Rezaie; Mehdi Nikkhah; Amir H Faraji; Gholamreza Hemmasi; Dhayaneethie Perumal; G Hossein Ashrafi; Fahimeh Safarnezhad Tameshkel; Esmaeel Gholizadeh; Mahmoodreza Khoonsari; Farhad Zamani
Journal:  Clin Cardiol       Date:  2022-04-14       Impact factor: 3.287

2.  Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang.

Authors:  Wenwen Yang; Rulin Ma; Xianghui Zhang; Heng Guo; Jia He; Lei Mao; Lati Mu; Yunhua Hu; Yizhong Yan; Jiaming Liu; Jiaolong Ma; Shugang Li; Yusong Ding; Mei Zhang; Jingyu Zhang; Shuxia Guo
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

3.  Impact of interactions among metabolic syndrome components on the development of cardiovascular disease among Kazakhs in Xinjiang.

Authors:  Wenwen Yang; Xiang Gao; Xianghui Zhang; Yunhua Hu; Heng Guo; Kui Wang; Yizhong Yan; Jia He; Jingyu Zhang; Jiaolong Ma; Lei Mao; Lati Mu; Jiaming Liu; Shugang Li; Yusong Ding; Mei Zhang; Rulin Ma; Shuxia Guo
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

4.  An exploratory analysis of dynamic change of metabolic syndrome in relation to the risk of developing cardiovascular disease in a chinese cohort.

Authors:  H Zhou; Zr Guo; Xs Hu; Lg Yu; Bh Xu; M Wu; Zy Zhou; C Yang
Journal:  Iran J Public Health       Date:  2012-04-30       Impact factor: 1.429

5.  Effect of metabolic syndrome on coronary heart disease in rural minorities of Xinjiang: a retrospective cohort study.

Authors:  Changjing Li; Jia He; Bin Wei; Xianghui Zhang; Xinping Wang; Jingyu Zhang; Kui Wang; Yunhua Hu; Lati Mu; Yizhong Yan; Jiaolong Ma; Yanpeng Song; Heng Guo; Rulin Ma; Shuxia Guo
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

6.  Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study.

Authors:  Eun Young Lee; Kyungdo Han; Da Hye Kim; Yong-Moon Park; Hyuk-Sang Kwon; Kun-Ho Yoon; Mee Kyoung Kim; Seung-Hwan Lee
Journal:  Cardiovasc Diabetol       Date:  2020-09-29       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.